Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ma Xing Zhi Xiao granules in chronic persistent bronchial asthma (heat wheezing pattern)
CTR20202632Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Dec 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Maxing Zhixiao Granule in asthma, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Dec 2020; status: completed.
02
Drugs
Maxing Zhixiao Granule
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20202632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202632.